Calcitonin human
As of the edition of 20 October 2026, Calcitonin human is a protein: marketed, first approved in 1986 (US); acts on CALCR; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1986
- Kind
- Protein
- Brand name
- Cibacalcin
- First approved
- 31 October 1986 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Novartis
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| CALCR | Calcitonin receptor | P30988 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Novartis | Applicant | 1986 to now |